These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacological treatment of biliary cirrhosis with ursodeoxycholic acid. Abbas G; Lindor KD Expert Opin Pharmacother; 2010 Feb; 11(3):387-92. PubMed ID: 20102304 [TBL] [Abstract][Full Text] [Related]
3. Methotrexate therapy for primary biliary cirrhosis. Bach N; Bodian C; Bodenheimer H; Croen E; Berk PD; Thung SN; Lindor KD; Therneau T; Schaffner F Am J Gastroenterol; 2003 Jan; 98(1):187-93. PubMed ID: 12526956 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of cholestatic liver diseases with ursodeoxycholic acid]. Boberg KM; Schrumpf E Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890 [TBL] [Abstract][Full Text] [Related]
5. Advances in the therapy of cholestatic liver disease. Roda E; Parini P; Bazzoli F; Mazzella G; Festi D; Aldini R Hepatogastroenterology; 1992 Feb; 39 Suppl 1():53-5. PubMed ID: 1577396 [No Abstract] [Full Text] [Related]
6. Search for medical treatment for primary biliary cirrhosis. LaRusso N Lancet; 1997 Oct; 350(9084):1046. PubMed ID: 10213545 [No Abstract] [Full Text] [Related]
7. The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis. Kaplan MM Semin Liver Dis; 1997 May; 17(2):129-36. PubMed ID: 9170200 [TBL] [Abstract][Full Text] [Related]
8. [Infrequent but serious: autoimmune hepatitis and primary biliary cirrhosis. Early therapy improves long-term prognosis]. MMW Fortschr Med; 2008 Apr; 150(15):45. PubMed ID: 18510120 [No Abstract] [Full Text] [Related]
9. Treatment with immunosuppressives in patients with primary biliary cirrhosis who fail to respond to ursodiol. Kaplan MM; Poupon R Hepatology; 2009 Aug; 50(2):652. PubMed ID: 19309721 [No Abstract] [Full Text] [Related]
10. Medical treatment of primary biliary cirrhosis. Kaplan MM Semin Liver Dis; 1989 May; 9(2):138-43. PubMed ID: 2658104 [No Abstract] [Full Text] [Related]
11. Reflections on therapeutic trials in primary biliary cirrhosis. Combes B Hepatology; 2005 Nov; 42(5):1009. PubMed ID: 16250047 [No Abstract] [Full Text] [Related]
12. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents. Silveira MG; Lindor KD Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189 [TBL] [Abstract][Full Text] [Related]
13. Antifibrotic therapy of liver cirrhosis, with special reference to primary biliary cirrhosis: promises and limitations. Jansen PL Neth J Med; 1992 Apr; 40(3-4):209-14. PubMed ID: 1603214 [No Abstract] [Full Text] [Related]
14. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy. Babatin MA; Sanai FM; Swain MG Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885 [TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid therapy in primary biliary cirrhosis. Podda M; Crosignani A; Battezzati PM; Quagliuolo M; Valsania C; Invernizzi P; Zuin M Ital J Gastroenterol; 1996; 28(2):114-7. PubMed ID: 8782007 [TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and therapy of primary biliary cirrhosis and primary sclerosing cholangitis]. Stiehl A Z Gastroenterol; 2002 Dec; 40 Suppl 2():29-30. PubMed ID: 12467002 [No Abstract] [Full Text] [Related]
17. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904 [TBL] [Abstract][Full Text] [Related]